Management of Monoamine Oxidase Inhibitor-treated Patients in the Emergency and Critical Care Setting

Monoamine oxidase inhibitors (MAOIs) are the most effective treatment for some forms of depression. Unfortunately, these agents cause many adverse reactions and interact with a number of other drugs. We review the pharmacology, side effects, and interactions of MAOIs, and focus on how MAOI-treated patients can be safely managed in critical care settings.

[1]  K. Shulman,et al.  Dietary Restriction, Tyramine, and the Use of Monoamine Oxidase Inhibitors , 1989, Journal of clinical psychopharmacology.

[2]  B. Walsh,et al.  'Spontaneous' hypertensive episodes with monoamine oxidase inhibitors. , 1988, The Journal of clinical psychiatry.

[3]  S. Linter,et al.  Monoamine oxidase inhibitors and anaesthesia. A review. , 1988, British journal of anaesthesia.

[4]  S. Linter,et al.  Monoamine Oxidase Inhibitors and Narcotic Analgesics , 1987, British Journal of Psychiatry.

[5]  E. Schweizer,et al.  Treatment of MAOI hypertensive crisis with sublingual nifedipine. , 1987, The Journal of clinical psychiatry.

[6]  C. A. Sides.  Hypertension during anaesthesia with monoamine oxidase inhibitors , 1987, Anaesthesia.

[7]  V. Salanga,et al.  Phenelzine toxicity responsive to dantrolene , 1987, Neurology.

[8]  R. Belmaker,et al.  Treating resistant depression , 1987 .

[9]  Lin Ls.  Mysterious MAOI hypertensive episodes. , 1986 .

[10]  Cameron Ag.  Monoamine oxidase inhibitors and general anaesthesia. , 1986 .

[11]  R. Kaplan,et al.  Phenelzine overdose treated with dantrolene sodium. , 1986, JAMA.

[12]  R. McCarthy,et al.  Monoamine Oxidase Inhibitors: Should They Be Discontinued Preoperatively? , 1985, Anesthesia and analgesia.

[13]  R. Baldessarini.  Chemotherapy in psychiatry : principles and practice , 1985 .

[14]  K. Freese.  Can Patients Safely Undergo Electroconvulsive Therapy While Receiving Monoamine Oxidase Inhibitors? , 1985, Convulsive therapy.

[15]  K. Shulman,et al.  Diet and Monoamine Oxidase Inhibitors: A Re-Examination , 1984, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[16]  B. Rumack,et al.  Monoamine oxidase inhibitor overdose. , 1984, Annals of emergency medicine.

[17]  P. Barash,et al.  Anesthesia for cardiac surgery in patients receiving monoamine oxidase inhibitors. , 1984, Anesthesia and analgesia.

[18]  J. Davidson,et al.  Practical aspects of MAO inhibitor therapy. , 1984, The Journal of clinical psychiatry.

[19]  J. Mann,et al.  Studies of selective and reversible monoamine oxidase inhibitors. , 1984, The Journal of clinical psychiatry.

[20]  G. Simpson,et al.  Tyramine studies and the safety of MAOI drugs. , 1984, The Journal of clinical psychiatry.

[21]  D. Murphy,et al.  New contributions from basic science to understanding the effects of monoamine oxidase inhibiting antidepressants. , 1984, The Journal of clinical psychiatry.

[22]  J. Davidson,et al.  Patient compliance with MAO inhibitor therapy. , 1984, The Journal of clinical psychiatry.

[23]  S. Zisook.  Side effects of isocarboxazid. , 1984, The Journal of clinical psychiatry.

[24]  G. Simpson,et al.  The combined use of MAOIs and tricyclics. , 1984, The Journal of clinical psychiatry.

[25]  E. A. Burch.  The Practitioner's Guide to Psychoactive Drugs, ed 2 , 1983 .

[26]  D. Folks.  Monoamine oxidase inhibitors: reappraisal of dietary considerations. , 1983, Journal of clinical psychopharmacology.